AC Immune
ACIU
32 hedge funds and large institutions have $157M invested in AC Immune in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 6 closing their positions.
245% more capital invested
Capital invested by funds: $45.5M → $157M (+$111M)
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
64% more call options, than puts
Call options by funds: $422K | Put options by funds: $258K
14% more funds holding
Funds holding: 28 → 32 (+4)
12.68% more ownership
Funds ownership: 19.11% → 31.79% (+13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$23M |
| 2 |
BlackRock
New York
|
+$7.76M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$6.43M |
| 4 |
Morgan Stanley
New York
|
+$5.7M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$4.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$230K |
| 2 |
BCV
Banque Cantonale Vaudoise
Lausanne,
Switzerland
|
-$83.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$60.6K |
| 4 |
LBC
Lawrence B. Cohen
|
-$36.6K |
| 5 |
Renaissance Technologies
New York
|
-$24.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
BNP Paribas Financial Markets
Paris,
France
| $13.3K | +$8.58K | +2,669 | New |
|
|
EDRH
27
Edmond de Rothschild Holding
Chambesy,
Switzerland
| $10K | – | – | – |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $10K | – | – | – |
|
29
Citigroup
New York
| $7.57K | +$4.87K | +1,514 | New |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $3.89K | -$60.6K | -18,860 | -96% |
|
31
Bank of America
Charlotte,
North Carolina
| $1.29K | +$829 | +258 | New |
|
|
SFCL
32
Strengthening Families & Communities LLC
Boston,
Massachusetts
| $1K | – | – | – |
|
|
33
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$230K | -71,487 | Closed |
|
|
LBC
34
Lawrence B. Cohen
| – | -$36.6K | -12,850 | Closed |
|
35
Group One Trading
Chicago,
Illinois
| – | -$16.9K | -5,255 | Closed |
|
36
Citadel Advisors
Miami,
Florida
| – | -$3.53K | -1,097 | Closed |
|
37
Simplex Trading
Chicago,
Illinois
| – | -$1.78K | -553 | Closed |
|
38
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$530 | -186 | Closed |
|
ACIU Hedge Fund Activity: Q4 2023 in Review
32 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2023, worth a combined $157M — up 245% from $45.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ACIU positions and 6 closed out — a net gain of 4 holders — while 9 added to existing stakes and 3 trimmed.
The largest buyer was BVF Inc, adding an estimated $23M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $230K sold.
- 32 institutional investors held AC Immune (ACIU) as of Q4 2023, up from 28 in Q3 2023.
- Funds reported $157M of AC Immune stock for Q4 2023, up 245% quarter-over-quarter.
- 10 funds opened new AC Immune positions in Q4 2023 and 6 closed out, a net change of +4 holders.
- The largest AC Immune buyer in Q4 2023 was BVF Inc, an estimated $23M added.
- The largest AC Immune seller in Q4 2023 was Susquehanna International Group, an estimated $230K sold.
Based on aggregated 13F filings for Q4 2023.